Published in Am J Kidney Dis on July 29, 2010
Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65
Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.35
Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis (2012) 1.26
Depression, insomnia and sleep apnea in patients on maintenance hemodialysis. Indian J Nephrol (2011) 1.05
The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis (2012) 1.04
The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One (2014) 0.92
Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials. Blood Purif (2011) 0.92
Cognitive impairment in dialysis patients: focus on the blood vessels? Am J Kidney Dis (2013) 0.84
Depressive affect and hospitalization risk in incident hemodialysis patients. Clin J Am Soc Nephrol (2014) 0.82
Depression and all-cause mortality in hemodialysis patients. Am J Nephrol (2014) 0.81
Diffuse interstitial brain edema in patients with end-stage renal disease undergoing hemodialysis: a tract-based spatial statistics study. Medicine (Baltimore) (2014) 0.81
Depression and life quality in chronic renal failure patients with polyneuropathy on hemodialysis. Ann Rehabil Med (2012) 0.78
Cognitive impairment and depression in a population of patients with chronic kidney disease in Colombia: a prevalence study. Can J Kidney Health Dis (2016) 0.77
Relationship between cognitive impairment and depression in dialysis patients. Yonsei Med J (2013) 0.77
Remote ischaemic conditioning-therapeutic opportunities in renal medicine. Nat Rev Nephrol (2013) 0.76
Cognitive impairment in chronic kidney disease: keep vascular disease in mind. Kidney Int (2014) 0.75
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients. Am J Nephrol (2016) 0.75
Prevalence and related factors of depressive symptoms in hemodialysis patients in northern China. BMC Psychiatry (2017) 0.75
L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis. Lett Drug Des Discov (2017) 0.75
[Decline in renal function in old age : Part of physiological aging versus age-related disease]. Z Gerontol Geriatr (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care (2004) 12.32
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int (2008) 3.34
Executive dysfunction and the course of geriatric depression. Biol Psychiatry (2005) 2.56
Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50
Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry (1999) 2.45
Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry (2006) 2.41
Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int (2009) 2.30
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol (2006) 2.23
Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis (1997) 2.09
Pseudodementia. Current concepts and future directions. Arch Gen Psychiatry (1981) 2.03
A meta-analysis of depression severity and cognitive function. J Affect Disord (2009) 1.94
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91
High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis (2007) 1.88
Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88
The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int (2006) 1.73
Does depression precede or follow executive dysfunction? Outcomes in older primary care patients. Am J Psychiatry (2007) 1.72
Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc (2008) 1.48
The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci (2004) 1.46
Validation of depression screening scales in patients with CKD. Am J Kidney Dis (2009) 1.43
Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.43
Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry (2005) 1.41
Subcortical cognitive impairment in dialysis patients. Hemodial Int (2007) 1.38
Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci (1995) 1.36
Executive dysfunction, heart disease burden, and remission of geriatric depression. Neuropsychopharmacology (2004) 1.34
Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc (2003) 1.32
Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health (2009) 1.26
The cognitive neuropsychology of depression in the elderly. Psychol Med (2007) 1.22
Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int J Geriatr Psychiatry (2008) 1.03
Behavioral compliance with dialysis prescription in hemodialysis patients. J Am Soc Nephrol (1995) 1.02
Longitudinal increase in the volume of white matter hyperintensities in late-onset depression. Int J Geriatr Psychiatry (2002) 1.00
Late life depression with cognitive impairment: evaluation and treatment. Clin Interv Aging (2009) 0.99
The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT study. Int J Geriatr Psychiatry (2007) 0.97
The association of depressive symptoms with survival in a Dutch cohort of patients with end-stage renal disease. Nephrol Dial Transplant (2009) 0.97
Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older. J Affect Disord (2008) 0.95
Cognitive impairment after stroke - impact on activities of daily living and costs of care for elderly people. The Göteborg 70+ Stroke Study. Cerebrovasc Dis (2004) 0.94
Subclinical vascular disease of the brain in dialysis patients. Am J Kidney Dis (2007) 0.93
Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med (2009) 0.91
Population projection of US adults with lifetime experience of depressive disorder by age and sex from year 2005 to 2050. Int J Geriatr Psychiatry (2008) 0.91
Functional impairment, depression, and life satisfaction among older hemodialysis patients and age-matched controls: a prospective study. Arch Phys Med Rehabil (2000) 0.88
Cerebral magnetic resonance T2 high intensities in end-stage renal disease. Stroke (1997) 0.87
Cerebrovascular risk factors and incident depression in community-dwelling elderly. Acta Psychiatr Scand (2008) 0.85
Depressive symptoms predict the subsequent risk of bodily pain in dialysis patients: Japan Dialysis Outcomes and Practice Patterns Study. Pain Med (2009) 0.83
Cognitive function and adherence of older adults undergoing hemodialysis. Nephrol Nurs J (2008) 0.81
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA (2005) 9.61
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med (2002) 4.24
A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA (2002) 3.65
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol (2007) 3.48
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Parental perspectives on end-of-life care in the pediatric intensive care unit. Crit Care Med (2002) 2.81
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int (2004) 2.38
Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens (2006) 2.34
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol (2002) 2.25
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22
High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr (2005) 2.18
The homocysteine hypothesis of depression. Am J Psychiatry (2007) 2.17
Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2006) 2.16
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis (2006) 2.16
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91
Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet (2010) 1.91
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82
The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis (2011) 1.79
Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol (2005) 1.79
Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers (2009) 1.77
Tai Chi on psychological well-being: systematic review and meta-analysis. BMC Complement Altern Med (2010) 1.76
Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care (2009) 1.74
Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes (2009) 1.71
Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol (2006) 1.70
Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol (2012) 1.69
Body mass index and mortality in CKD. Am J Kidney Dis (2007) 1.68
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol (2005) 1.68
Evidence of systematic duplication by new percutaneous coronary intervention programs. Circ Cardiovasc Qual Outcomes (2013) 1.66
Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med (2010) 1.66
A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes (2011) 1.63
Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology (2010) 1.60
Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis (2008) 1.60
Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis (2010) 1.60
Relationship between homocysteine and mortality in chronic kidney disease. Circulation (2006) 1.58
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int (2010) 1.55
Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis (2007) 1.53
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens (2006) 1.51
Use of the electrocardiograph-based thrombolytic predictive instrument to assist thrombolytic and reperfusion therapy for acute myocardial infarction. A multicenter, randomized, controlled, clinical effectiveness trial. Ann Intern Med (2002) 1.49
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis (2005) 1.49
Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2011) 1.47
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis (2008) 1.46